Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-20

Clinical Trial Update: Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating chemotherapy plus pamidronate for newly diagnosed osteosarcoma completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pamidronate (pamidronate disodium)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-20